International Stem Cell net loss turns to USD 71,000 in Q2 FY26; product sales rise 9% to USD 2.68 million vs Q2 FY25
Reuters2026/08/13 20:02Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- International Stem Cell posted a net loss of $71,000 for the quarter ended June 30, 2026, versus net income of $129,000 a year earlier.
- Product sales rose 9% to $2.68 million, while cost of sales climbed 31% to $1.22 million.
- General and administrative expenses increased 17% to $1.06 million, driven by higher legal and consulting costs tied to strategic activities.
- Research and development spending edged down 4% to $155,000, while selling and marketing costs slipped 3% to $276,000.
- The company reiterated it has no revenue from therapeutic product development and cited substantial doubt about its ability to continue as a going concern.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. International Stem Cell Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-349108), on August 13, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Dark Defender Here’s Why Ripple CEO Can’t Say a Price for XRP
TimesTabloid•2026/09/06 18:03
Defence Therapeutics completes $9.6 million private placement at $0.55 per unit
Reuters•2026/09/06 17:14
Cyclezyme to buy Ragn-Sells melanin patent, pays via shares for 7.9% stake
Reuters•2026/09/06 16:45
8 in a Row: Ripple (XRP) ETFs Record Another Green Week but Warning Signs Return
Cryptopotato•2026/09/06 16:21

Crypto prices
MoreBitcoin
BTC
$79,888.46
-0.17%
Ethereum
ETH
$2,494.92
+0.63%
Tether USDt
USDT
$0.9999
-0.01%
BNB
BNB
$748.1
-3.57%
XRP
XRP
$1.41
-0.66%
USDC
USDC
$0.9999
-0.00%
Solana
SOL
$106.35
+2.26%
TRON
TRX
$0.3352
+0.29%
Hyperliquid
HYPE
$87.92
+2.66%
Zcash
ZEC
$1,227.06
+18.67%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now